Applications of magnetic microbubbles for Theranostics

Theranostics

Volumn 2, Issue 1, 2012, Pages 103-112

  Cai, Xiaowei ^a   Yang, Fang ^a   Gu, Ning ^a  

^a Southeast University   (China)

Author keywords

Drug delivery system; Dual modality imaging; Magnetic microbubble; Molecular imaging

Indexed keywords

CD51 ANTIGEN; CHELATING AGENT; CONTRAST MEDIUM; CYANOACRYLATE DERIVATIVE; ENDOGLIN; LUCIFERASE; MAGNETIC NANOPARTICLE; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; SMALL INTERFERING RNA; SUPERPARAMAGNETIC IRON OXIDE; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN RECEPTOR 2;

ADVERSE DRUG REACTION; ANGIOGENESIS; ATHEROSCLEROSIS; CANCER GENE THERAPY; CARDIOVASCULAR DISEASE; CYTOTOXICITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG TARGETING; ECHOGRAPHY; EPITHELIUM CELL; FIBROBLAST; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; MICROBUBBLE; MOLECULAR IMAGING; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REPORTER GENE; REVIEW; STATIC ELECTRICITY; THERAPY;

EID: 84864570072     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.3464     Document Type: Review

References (51)

1. Ke H, Wang J, Dai Z, et al. Gold-nanoshelled microcapsules: a theranostic agent for ultrasound contrast imaging and photo-thermal therapy. Angew Chem Int Ed 2011; 123: 3073-7.
2. Wink MH, Wijkstra H, Rosette JJ, Grimbergen CA. Ultrasound imaging and contrast agents: A safe alternative to MRI? Minim Invasive Ther 2006; 15(2): 93-100.
3. Yang F, Li L, Li Y, et al. Superparamagnetic nanoparticle-inclusion microbubbles for ultrasound contrast agents. Phys Med Biol 2008; 53: 6129-41.
4. Lindner JR, Song J, Jayaweera AR, Sklenar J, Kaul S. Microvascular rheology of definity microbubbles after intra-arterial and intravenous administration. J Am Soc Echocardiogr 2002; 15(5): 396-403.
5. Ismail S, Jayaweera AR, Camarano G, Gimple LW, Powers ER, Kaul S. Relation between air-filled albumin microbubble and red blood cell rheology in the human myocardium: influence of echocardiographic systems and chest wall attenuation. Circulation 1996; 94 (3): 445-51.
6. Wu J, Ross JP, Chiu JF. Reparable sonoporation generated by microstreaming. J Acoust Soc Am 2002; 111: 1460-4.
7. Yang F, Gu N, Chen D, et al. Experimental study on cell self-sealing during sonoporation. J Control Release 2008; 131: 205-10.
8. Lentacker I, Geers B, Demeester J, et al. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol Ther.2010; 18: 101-8.
9. Ohta S, Suzuki K, Ogino K, et al. Gene transduction by sonoporation. Develop Grouth Differ 2008; 50: 517-20.
10. Deckers R, Moonen CT. Ultrasound triggered, image guided, local drug delivery. J Controlled Release 2010; 148: 25-33.
11. Larina IV, Evers BM, Esenaliev RO. Optimal drug and gene delivery in cancer cells by ultrasound-induced cavitation. Anticancer Res 2005; 25: 149-56.
12. Reslan L, Mestas JL, Herveau S, et al. Transfection of cells in suspension by ultrasound cavitation. J Control Release 2010; 142: 251-8.
13. Park JI, Jagadeensan D, Williams R, et al. Microbubbles loaded with nanoparticles: a route to multiple imaging modalities. ACS Nano 2010; 4: 6579-86.
14. Stride E, Edirisinghe M. Novel microbubble preparation tech-nologies. Soft matter 2008; 4: 2350-9.
15. Zhang Y, Yang Y, Cai W. Multimodality imaging of integrin αvβ3 expression. Theranostics 2011; 1: 135-48.
16. Kiessling F, Gaetjens J, Palmowski M. Application of molecular ultrasound for imaging integrin expression. Theranostics 2011; 1: 127-34.
17. Liu Z, Lammers T, Ehling J, et al. Iron oxide nanoparti-cle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging. Biomaterials 2011; 32: 6155-63.
18. Laurent S, Forge D, Port M, et al. Magnetic iron oxide nanopar-ticles: Synthesis, Stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008; 108: 2064-110.
19. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005; 26: 3995-4021.
20. Konczol M, Ebeling S, Goldenberg E, et al. Cytotoxicity and genotoxicity of size-fractionated iron oxide (magnetite) in A549 human lung epithelial cells: role of ROS, JNK, and NF-κ.B. Chem Res Toxicol 2011; 24: 1460-75.
21. Silva AC, Oliveira TR, Mamani JB, et al. Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int J Nanomed 2011; 6: 591-603.
22. Yu M, Park J, Jon J. Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2012; 2: 3-44.
23. Yang F, Li Y, Chen Z, et al. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging. Biomaterials 2009; 30: 3882-90.
24. 4 nanoparticles in encapsulated microbubbles to tumor cells via sonoporation and associated cellular bioeffects. Small 2011; 7: 902-10.
25. Soetanto K, Watarai H. Development of magnetic microbubbles for drug delivery system (DDS). Jpn J Appl Phys 2000; 39: 3230-2.
26. Wong KK, Huang I, Kim YR, et al. In vivo study of microbubbles as an MR susceptibility contrast agent. Magn Reson Med 2004; 52: 445-52.
27. Chow AM, Chan WY, Cheung JS, Wu EX. Enhancement of gas-filled microbubble R2* by iron oxide nanoparticles for MRI. Magn Reson Med 2010; 63: 224-9.
28. Wu J, Poi HL, Bin J, et al. Efficacy of contrast-enhanced US and magnetic microbubbles targeted to vascular cell adhesion molecule-1 foe molecular imaging of atherosclerosis. Radiology 2011; 260: 463-71.
29. Bin J, Wu J, Yang L, et al. In vivo assessment of novel magnetic microbubbles targeted to P-selectin for inflammatory molecular imaging in high-shear flow. Circulation. 2009; 120: S327.
30. Nahrendorf M, Sosnovik DE. Science to practice: will magnetic guidance of microbubbles play a role in clinical molecular imaging? Radiology 2011; 260: 309-10.
31. Unger E, McCreery T, Sweitzer R, et al. Acoustically active lipospheres containing paclitaxel - A new therapeutic ultrasound contrast agent. Invest Radiol 1998; 33: 886-92.
32. Zhao Y, Liang H, Mei X, Halliwell M. Preparation, characterization and in vivo observation of phospholipid-based gasfilled microbubbles containing hirudin. Ultrasound Med Biol 2005; 31: 1237-43.
33. Christiansen C, Kryvi H, Sontum P, Skotland T. Physical and biochemical-characterization of albunex (TM): A new ultrasound contrast agent consisting of air-filled albumin microspheres suspended in a solution of human albumin. Biotechnol Appl Biochem 1994; 19: 307-20.
34. Bjerknes K, Dyrstad K, Smistad G, Agerkvist I. Preparation of polymeric microcapsules: Formulation studies. Drug Dev Ind Pharm 2000; 26: 847-56.
35. Jiang B, Gao C, Shen J. Polylactide hollow spheres fabricated by interfacial polymerization in an oil-in-water emulsion system. Colloid Polym Sci 2006; 284: 513-9.
36. Bao D, Zhang H, Liu X, Zhao Y, Ma X, and Yuan Q. Preparation of monodispersed polymer microspheres by SPG membrane emulsification-solvent evaporation technology. J Dispersion Sci Technol 2007; 28: 485-90.
37. Kukizakia M, Goto M. Spontaneous formation behavior of uniform-sized microbubbles from Shirasu porous glass (SPG) membranes in the absence of water-phase flow. Colloids Surf A 2007; 296: 174-81.
38. Bohmer M, Schroeders R, Steenbackkers J, et al. Preparation of monodisperse polymer particles and capsules by ink-jet printing. Colloids Surf A 2006; 289: 96-104.
39. Farook U, Zhang HB, Edirisinghe M, et al. Preparation of microbubble suspensions by co-axial electrohydrodynamic atomization. Med Eng Phys 2007; 29: 749-54.
40. Farook U, Stride E, Edirisinghe M, Moaleji R. Microbubbling by co-axial electrohydrodynamic atomization. Med Biol Eng Comput 2007; 45: 781-9.
41. Whitesides G. The origins and the future of microfluidics. Nature 2006; 442: 368-73.
42. Xu Q and Nakajima M. The generation of highly monodisperse droplets through the breakup of hydrodynamically focused microthread in a microfluidic device. Appl Phys Lett 2004; 85: 3726-8.
43. Garstecki P, Gitlin I, DiLuzio W, et al. Formation of monodisperse bubbles in a microfluidic flow-focusing device. Appl Phys Lett 2004; 85: 2649-51.
44. Pancholi K, Farook U, Moaleji R, et al. Novel methods of preparing phospholipid coated microbubbles. Eur Biophys J 2008; 37: 515-20.
45. Dharmakumar R, Plewes DB, Wright GA. A novel microbubble construct for intracardiac or intravascular MR manometry: a theoretical study. Phys Med Biol 2005; 50:4745-62.
46. Tu J, Guan J, Qiu Y, Matula TJ. Estimating the shell parameters of SonoVue® microbubbles using light scattering. J Acoust Soc Am 2009; 126 (6): 2954-9.
47. Klibanov AL. Ultrasound molecular imaging with targeted microbubble contrast agents. J Nucl Cardiol 2007; 14: 876-84.
48. Jeong B, Bae YH, Lee DS, Kim SW. Biodegradable block co-polymers as injectable drug-delivery systems. Nature 1997; 388: 860-2.
49. Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science 2004; 303: 1818-22.
50. Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 2001; 73: 137-72.
51. Vlaskou D, Mykhaylyk O, Krotz F, et al. Magnetic and acoustically active lipospheres for magnetically targeted nucleic acid delivery. Adv Funct Mater 2010; 20: 3881-94.